Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 175 Pages
Report ld: 5346668
Request Sample
Customized Report
MR Imaging in Neurosurgery Market Size(US$)

CAGR 2025-2031
3.4%
Market Size,2031
USD 8,376
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global MR Imaging in Neurosurgery market is projected to grow from US$ 6650 million in 2024 to US$ 8376 million by 2031, at a CAGR of 3.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
MRI is diagnostic equipment that uses a magnetic field and radio waves to create detailed images of the organs and tissues within your body.
MRI gives different information about structures in the body that can be seen with an X-ray, ultrasound, or computed tomography (CT) scan.
MRI can make cross-sectional, sagittal, and coronal layer images of various ramps. MRI is used to detect brain hematoma, cerebral hematoma, brain tumors, intracranial aneurysms, arteriovenous malformations, cerebral ischemia, spinal tumors, spinal cord syringomyelia and hydrocephalus and other common brain diseases. Due to MRI has many applications, Neuro Imaging is only one of those applications. So in this report we study all the MRI System.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global MR Imaging in Neurosurgery market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the MR Imaging in Neurosurgery study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to MR Imaging in Neurosurgery: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global MR Imaging in Neurosurgery Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Traditional MR Imaging Device
1.2.3 Robot Supports MR Imaging Device
1.3 Market Segmentation by Application
1.3.1 Global MR Imaging in Neurosurgery Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global MR Imaging in Neurosurgery Revenue Estimates and Forecasts 2020-2031
2.2 Global MR Imaging in Neurosurgery Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global MR Imaging in Neurosurgery Sales Estimates and Forecasts 2020-2031
2.4 Global MR Imaging in Neurosurgery Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global MR Imaging in Neurosurgery Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global MR Imaging in Neurosurgery Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Traditional MR Imaging Device Market Size by Manufacturers
3.5.2 Robot Supports MR Imaging Device Market Size by Manufacturers
3.6 Global MR Imaging in Neurosurgery Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global MR Imaging in Neurosurgery Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global MR Imaging in Neurosurgery Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global MR Imaging in Neurosurgery Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global MR Imaging in Neurosurgery Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America MR Imaging in Neurosurgery Sales and Revenue by Type (2020-2031)
6.4 North America MR Imaging in Neurosurgery Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America MR Imaging in Neurosurgery Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe MR Imaging in Neurosurgery Sales and Revenue by Type (2020-2031)
7.4 Europe MR Imaging in Neurosurgery Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe MR Imaging in Neurosurgery Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific MR Imaging in Neurosurgery Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific MR Imaging in Neurosurgery Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific MR Imaging in Neurosurgery Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America MR Imaging in Neurosurgery Sales and Revenue by Type (2020-2031)
9.4 Central and South America MR Imaging in Neurosurgery Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America MR Imaging in Neurosurgery Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa MR Imaging in Neurosurgery Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa MR Imaging in Neurosurgery Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa MR Imaging in Neurosurgery Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 AiM Medical Robotics
11.1.1 AiM Medical Robotics Corporation Information
11.1.2 AiM Medical Robotics Business Overview
11.1.3 AiM Medical Robotics MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.1.4 AiM Medical Robotics MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 AiM Medical Robotics MR Imaging in Neurosurgery Sales by Product in 2024
11.1.6 AiM Medical Robotics MR Imaging in Neurosurgery Sales by Application in 2024
11.1.7 AiM Medical Robotics MR Imaging in Neurosurgery Sales by Geographic Area in 2024
11.1.8 AiM Medical Robotics MR Imaging in Neurosurgery SWOT Analysis
11.1.9 AiM Medical Robotics Recent Developments
11.2 Brainlab AG
11.2.1 Brainlab AG Corporation Information
11.2.2 Brainlab AG Business Overview
11.2.3 Brainlab AG MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.2.4 Brainlab AG MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Brainlab AG MR Imaging in Neurosurgery Sales by Product in 2024
11.2.6 Brainlab AG MR Imaging in Neurosurgery Sales by Application in 2024
11.2.7 Brainlab AG MR Imaging in Neurosurgery Sales by Geographic Area in 2024
11.2.8 Brainlab AG MR Imaging in Neurosurgery SWOT Analysis
11.2.9 Brainlab AG Recent Developments
11.3 Deerfield Management
11.3.1 Deerfield Management Corporation Information
11.3.2 Deerfield Management Business Overview
11.3.3 Deerfield Management MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.3.4 Deerfield Management MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Deerfield Management MR Imaging in Neurosurgery Sales by Product in 2024
11.3.6 Deerfield Management MR Imaging in Neurosurgery Sales by Application in 2024
11.3.7 Deerfield Management MR Imaging in Neurosurgery Sales by Geographic Area in 2024
11.3.8 Deerfield Management MR Imaging in Neurosurgery SWOT Analysis
11.3.9 Deerfield Management Recent Developments
11.4 FAULHABER
11.4.1 FAULHABER Corporation Information
11.4.2 FAULHABER Business Overview
11.4.3 FAULHABER MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.4.4 FAULHABER MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 FAULHABER MR Imaging in Neurosurgery Sales by Product in 2024
11.4.6 FAULHABER MR Imaging in Neurosurgery Sales by Application in 2024
11.4.7 FAULHABER MR Imaging in Neurosurgery Sales by Geographic Area in 2024
11.4.8 FAULHABER MR Imaging in Neurosurgery SWOT Analysis
11.4.9 FAULHABER Recent Developments
11.5 Fujifilm Holdings Corporation
11.5.1 Fujifilm Holdings Corporation Corporation Information
11.5.2 Fujifilm Holdings Corporation Business Overview
11.5.3 Fujifilm Holdings Corporation MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.5.4 Fujifilm Holdings Corporation MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Fujifilm Holdings Corporation MR Imaging in Neurosurgery Sales by Product in 2024
11.5.6 Fujifilm Holdings Corporation MR Imaging in Neurosurgery Sales by Application in 2024
11.5.7 Fujifilm Holdings Corporation MR Imaging in Neurosurgery Sales by Geographic Area in 2024
11.5.8 Fujifilm Holdings Corporation MR Imaging in Neurosurgery SWOT Analysis
11.5.9 Fujifilm Holdings Corporation Recent Developments
11.6 Hyperfine Inc.
11.6.1 Hyperfine Inc. Corporation Information
11.6.2 Hyperfine Inc. Business Overview
11.6.3 Hyperfine Inc. MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.6.4 Hyperfine Inc. MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Hyperfine Inc. Recent Developments
11.7 Insightec
11.7.1 Insightec Corporation Information
11.7.2 Insightec Business Overview
11.7.3 Insightec MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.7.4 Insightec MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Insightec Recent Developments
11.8 Zimmer Biomet Holdings, Inc.
11.8.1 Zimmer Biomet Holdings, Inc. Corporation Information
11.8.2 Zimmer Biomet Holdings, Inc. Business Overview
11.8.3 Zimmer Biomet Holdings, Inc. MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.8.4 Zimmer Biomet Holdings, Inc. MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Zimmer Biomet Holdings, Inc. Recent Developments
11.9 Synaptive Medical
11.9.1 Synaptive Medical Corporation Information
11.9.2 Synaptive Medical Business Overview
11.9.3 Synaptive Medical MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.9.4 Synaptive Medical MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Synaptive Medical Recent Developments
11.10 Profound Medical Corp.
11.10.1 Profound Medical Corp. Corporation Information
11.10.2 Profound Medical Corp. Business Overview
11.10.3 Profound Medical Corp. MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.10.4 Profound Medical Corp. MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Profound Medical Corp. Recent Developments
11.11 Promaxo Inc.
11.11.1 Promaxo Inc. Corporation Information
11.11.2 Promaxo Inc. Business Overview
11.11.3 Promaxo Inc. MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.11.4 Promaxo Inc. MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Promaxo Inc. Recent Developments
11.12 Monteris Medical Corporation
11.12.1 Monteris Medical Corporation Corporation Information
11.12.2 Monteris Medical Corporation Business Overview
11.12.3 Monteris Medical Corporation MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.12.4 Monteris Medical Corporation MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Monteris Medical Corporation Recent Developments
11.13 Medtronic plc
11.13.1 Medtronic plc Corporation Information
11.13.2 Medtronic plc Business Overview
11.13.3 Medtronic plc MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.13.4 Medtronic plc MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Medtronic plc Recent Developments
11.14 Koninklijke Philips N.V.
11.14.1 Koninklijke Philips N.V. Corporation Information
11.14.2 Koninklijke Philips N.V. Business Overview
11.14.3 Koninklijke Philips N.V. MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.14.4 Koninklijke Philips N.V. MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Koninklijke Philips N.V. Recent Developments
11.15 General Electric Company
11.15.1 General Electric Company Corporation Information
11.15.2 General Electric Company Business Overview
11.15.3 General Electric Company MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.15.4 General Electric Company MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 General Electric Company Recent Developments
11.16 Fonar Corporation
11.16.1 Fonar Corporation Corporation Information
11.16.2 Fonar Corporation Business Overview
11.16.3 Fonar Corporation MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.16.4 Fonar Corporation MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Fonar Corporation Recent Developments
11.17 Esaote S.p.A
11.17.1 Esaote S.p.A Corporation Information
11.17.2 Esaote S.p.A Business Overview
11.17.3 Esaote S.p.A MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.17.4 Esaote S.p.A MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Esaote S.p.A Recent Developments
11.18 Canon Inc.
11.18.1 Canon Inc. Corporation Information
11.18.2 Canon Inc. Business Overview
11.18.3 Canon Inc. MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.18.4 Canon Inc. MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Canon Inc. Recent Developments
11.19 Aspect Imaging Ltd.
11.19.1 Aspect Imaging Ltd. Corporation Information
11.19.2 Aspect Imaging Ltd. Business Overview
11.19.3 Aspect Imaging Ltd. MR Imaging in Neurosurgery Product Models, Descriptions and Specifications
11.19.4 Aspect Imaging Ltd. MR Imaging in Neurosurgery Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Aspect Imaging Ltd. Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 MR Imaging in Neurosurgery Industry Chain
12.2 MR Imaging in Neurosurgery Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 MR Imaging in Neurosurgery Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 MR Imaging in Neurosurgery Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 MR Imaging in Neurosurgery Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global MR Imaging in Neurosurgery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for MR Imaging in Neurosurgery was estimated to be worth US$ 6854 million in 2025 and is projected to reach US$ 8633 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 154
USD 3950.00
(Single User License)
The global MR Imaging in Neurosurgery market was valued at US$ 6854 million in 2025 and is anticipated to reach US$ 8633 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 134
USD 2900.00
(Single User License)
The global MR Imaging in Neurosurgery market size was US$ 6650 million in 2024 and is forecast to a readjusted size of US$ 8376 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 105
USD 4250.00
(Single User License)
The global market for MR Imaging in Neurosurgery was estimated to be worth US$ 6650 million in 2024 and is forecast to a readjusted size of US$ 8376 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 138
USD 3950.00
(Single User License)
The global market for MR Imaging in Neurosurgery was valued at US$ 6650 million in the year 2024 and is projected to reach a revised size of US$ 8376 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published Date: 2025-01-13
Pages: 101
USD 2900.00
(Single User License)
MRI is diagnostic equipment that uses a magnetic field and radio waves to create detailed images of the organs and tissues within your body.
Published Date: 2024-02-07
Pages: 100
USD 2900.00
(Single User License)
The global market for MR Imaging in Neurosurgery was estimated to be worth US$ 6854 million in 2025 and is projected to reach US$ 8633 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-06-16
Pages: 154
The global MR Imaging in Neurosurgery market was valued at US$ 6854 million in 2025 and is anticipated to reach US$ 8633 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-04-17
Pages: 134
The global MR Imaging in Neurosurgery market size was US$ 6650 million in 2024 and is forecast to a readjusted size of US$ 8376 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 105
The global market for MR Imaging in Neurosurgery was estimated to be worth US$ 6650 million in 2024 and is forecast to a readjusted size of US$ 8376 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 138
The global market for MR Imaging in Neurosurgery was valued at US$ 6650 million in the year 2024 and is projected to reach a revised size of US$ 8376 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published: 2025-01-13
Pages: 101
MRI is diagnostic equipment that uses a magnetic field and radio waves to create detailed images of the organs and tissues within your body.
Published: 2024-02-07
Pages: 100
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now